
Research compounds
5-Amino-1MQ
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule, not a peptide. It is a membrane-permeable inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT), reported in 2018 by a group at the University of Texas Medical Branch.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- 2 to 8 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 50 mg, lot 5AM1MQ50-0803: 99.87% purity (RP-HPLC), 50.98 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7587
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Diet-induced obesity in mice
- Fatty liver and glucose tolerance in mice
- Aged muscle regeneration in mice
- NAD+ and methylation metabolism
How it is thought to work
It inhibits NNMT, a cytosolic enzyme that methylates nicotinamide. In cultured fat cells, NNMT inhibitors lowered the reaction product 1-methylnicotinamide, raised NAD+ and S-adenosylmethionine, and suppressed lipogenesis. The authors propose that these shifts underlie the effects seen in mice; this has been shown only in cell and mouse studies.
Where the research stands
Preclinical research (mouse and cell studies). Published work is in mice and cells and comes largely from one research group and its affiliated company. No registered human trials were found on ClinicalTrials.gov.
Sources
- Neelakantan H, et al. (2018). Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology.
- Neelakantan H, et al. (2019). Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochemical Pharmacology.
- Babula JJ, et al. (2024). Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction. Diabetes, Obesity & Metabolism.
- Dimet-Wiley AL, et al. (2024). Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice. Scientific Reports.
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
